Aethlon Medical, Inc.

  • Home
  • The Hemopurifier®
    • The Hemopurifier® in Infectious Disease
    • The Hemopurifier® in Cancer
    • Resources
  • About
    • Overview
    • Exosome Sciences, Inc.
    • Executive Team
    • Board of Directors
    • Scientific Advisory Board
    • Contact Us
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Outside Media
  • Investors
    • Overview
    • Corporate News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    • IRS Form 8937
News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
  • Outside Media

Press Releases

Sep 30, 2021

Aethlon Medical Announces Contracting with PPD to Advance Hemopurifier Clinical Programs

Sep 7, 2021

Aethlon Medical to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

Aug 9, 2021

Aethlon Medical Announces First Quarter Financial Results and Provides Corporate Update

Jul 29, 2021

Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 9, 2021

Jun 24, 2021

Aethlon Medical Announces Fiscal Year End Financial Results and Provides Corporate Update

Jun 21, 2021

Aethlon Medical to Release Fourth Quarter Financial Results and Host Conference Call on June 24, 2021

Jun 10, 2021

Aethlon Medical Announces $12.425 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jun 3, 2021

Aethlon Medical Publishes Case Studies of Two Critically Ill COVID-19 Patients Treated with the Hemopurifier®

Mar 1, 2021

Aethlon Medical to Participate in Two Upcoming Healthcare Investor Conferences

Feb 10, 2021

Aethlon Medical Announces Third Quarter Financial Results and Provides Corporate Update

    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...20
    • Twitter
    • Linkedin
    • YouTube
    Privacy Policy Disclaimer Sitemap
    © 2022 Aethlon Medical, Inc. All Rights Reserved.